Clinical Trial Record

Return to Clinical Trials

Artificial Intelligence in Endoscopic Ultrasound


2024-01-19


2026-12


2027-12


310

Study Overview

Artificial Intelligence in Endoscopic Ultrasound

The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.

Endoscopic Ultrasound (EUS) is an equipment where an ultrasound transducer is attached to the tip of the endoscope. When advanced to the stomach the organs outside such as the pancreas and liver can be visualized in great detail. This enables diagnosis of conditions such as pancreatic cancer. However, an endoscopist must undergo training to accurately interpret these ultrasound images. The investigators are in the process of developing an artificial intelligence system that could potentially interpret EUS images. The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures. Such correlation if established will lead to possible development of an artificial intelligence platform that can diagnose pancreatic diseases. Such development will potentially minimize human error and decrease learning curve to gain proficiency in EUS.

  • Pancreatic Cancer
  • Pancreas Disease
  • Pancreatic Cyst
  • DEVICE: Patients undergoing endoscopic ultrasound procedures
  • 24.015.01

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2024-08-19  

N/A  

2025-05-27  

2024-08-19  

N/A  

2025-05-31  

2024-08-21  

N/A  

2024-08  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: Patients undergoing endoscopic ultrasound procedures

Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.

DEVICE: Patients undergoing endoscopic ultrasound procedures

  • Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.
Primary Outcome MeasuresMeasure DescriptionTime Frame
Rate of detection pancreatic abnormalities by AIAbility of AI to detect pancreatic abnormalities as identified by an endoscopist during EUS examination of the pancreas.1 day
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Rate of detection pancreatic solid mass lesions by AIAbility of AI to detect pancreatic solid mass lesions as identified by an endoscopist during EUS examination of the pancreas.1 day
Rate of detection pancreatic cystic lesions by AIAbility of AI to detect pancreatic cystic lesions as identified by an endoscopist during EUS examination of the pancreas.1 day

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Shyam Varadarajulu, MD

Phone Number: 321-841-2431

Email: shyam.varadarajulu@orlandohealth.com

Study Contact Backup

Name: Barbara Broome

Phone Number: 321-841-4356

Email: barbara.broome@orlandohealth.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Age ≥ 18 years
  • Any patient undergoing endoscopic ultrasound examination

  • Exclusion Criteria:

  • Age < 18 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Shyam Varadarajulu, MD, Orlando Health, Digestive Health Institute

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available